Anthracycline-induced cardiotoxicity: mechanisms of development and clinical manifestations

The review presents the recent data on anthracycline-induced cardiotoxicity, mechanisms of its development, predictive factors, risk factors, clinical manifestations and cumulative doses. There are also data on the relationship between anthracycline-containing antibiotics and other cardiotoxic agents, and on feasibility of prevention of anthracycline-induced cardiotoxicity.